Total Funding
93
91
Total FundingPost-IPO Equity raised
Growth Score
0 pts
Heat Score
55 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
87528
Dainippon Sumitomo Pharma is a pharmaceutical company based in Japan.
Masayo Tada: President & CEO
Antony Loebel: Executive Officer & Head of Global Clinical DevelopmentPast Role: Sunovion Pharmaceuticals, President and Chief Executive Officer
About the Company
"Green Prism", the symbol of Dainippon Sumitomo Pharma Co., Ltd. is a motif in the design of the "Sun"-expressing a lively sense of energy, moving on toward tomorrow; "Light"-to convey the potential and hope of the future; and "Flower"-engendering the joyous and liberated sensation of basking in good health.
A design crafted to embody preeminent research and development powers, a thorough support system, the spirit of challenge, and the other stances of Dainippon Sumitomo Pharma-a company bent on supplying all people with the strength to push on toward an even brighter tomorrow.
Emanating from the symbol, furthermore, is the image of a network, steadily spreading out into the world.
